Menu
0
Total price
0 €
PRICES include / exclude VAT
Homepage>PD CEN/TS 17390-3:2020 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood Preparations for analytical CTC staining
sklademVydáno: 2020-01-24
PD CEN/TS 17390-3:2020 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood Preparations for analytical CTC staining

PD CEN/TS 17390-3:2020

Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood Preparations for analytical CTC staining

Format
Availability
Price and currency
Anglicky Secure PDF
Immediate download
178.32 €
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
17.83 €
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
53.50 €
Anglicky Hardcopy
In stock
178.32 €
Označení normy:PD CEN/TS 17390-3:2020
Počet stran:22
Vydáno:2020-01-24
ISBN:978 0 539 12706 5
Status:Standard
DESCRIPTION

PD CEN/TS 17390-3:2020


This standard PD CEN/TS 17390-3:2020 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood is classified in these ICS categories:
  • 11.100.10 In vitro diagnostic test systems
This document gives guidelines on the handling, storage, processing and documentation of venous whole blood and the CTC (Circulating Tumor Cell) enrichment, CTC isolation and other preparations for analytical staining (i.e., conventional cytochemical and immunocytochemical staining) of CTCs during the pre-examination Phase before the cytopathological evaluation is performed. This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. This document does not cover specific staining procedures. NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.